Topics
September 2017 | Up Front
Medical Editors' Page
Allen C. Ho, MD, and Robert L. Avery, MD
July 10, 2026
Opus Genetics Provides BEST1 Program Update
July 9, 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema
Teva, Samsung Bioepis Sign Canadian Commercialization Agreement for Aflibercept Biosimilar
Atsena Selects Lead Clinical Candidate for Stargardt Disease Gene Therapy
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
